论文部分内容阅读
纤溶酶原转变成有纤溶活性的纤溶酶是纤溶过程决定性的一步?t-PA是体内主要的纤溶酶原激活物之一,而纤溶酶原激活剂抑制物(Plasminogen Activator Inhibitor PAI)是组织型纤溶酶原激活剂(t-PA)和尿激酶纤溶酶原激活剂(u-PA)的快速抑制剂,在纤溶系统中起着关键性调节作用?自1983
The conversion of plasminogen to fibrinolytic plasminogen is a crucial step in the fibrinolytic process. T-PA is one of the major plasminogen activators in the body, whereas plasminogen activator inhibitor (Plasminogen Activator Inhibitor PAI is a rapid inhibitor of tissue-type plasminogen activator (t-PA) and urokinase plasminogen activator (u-PA) and plays a key regulatory role in the fibrinolytic system. Since 1983